Navigation Links
Scientists work to identify genes that contribute to early heart attack risk

Scientists at Wake Forest University Baptist Medical Center and colleagues at four other medical centers have launched a $10 million multi-year study to identify genes that may contribute to early atherosclerosis.

"If we can identify people in their teens and early adult life who have a genetic predisposition to develop atherosclerosis, we can manage their risk factors for heart disease and stroke sooner and more aggressively," said David Herrington, M.D., M.H.S., professor of cardiology at Wake Forest and lead investigator.

Other participating centers are Cedars Sinai Medical Center, Louisiana State University (LSU) Health Sciences Center in New Orleans, the University of Texas Health Science Center at Houston and the University of Washington.

Funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, the study, known as SEA (SNPs and Extent of Atherosclerosis), will build on research from two previously funded NHLBI projects. The study will also benefit from a unique collaboration with Perlegen Sciences Inc., a company that specializes in techniques to uncover the genetic causes of diseases.

Atherosclerosis is the development of fatty deposits in arteries that leads to blood clot formation, angina, heart attack and stroke. This process can begin in childhood and early adult life. Doctors have known that genetic factors contribute to risk for early atherosclerosis but the exact genes involved are not yet known.

"We hope the SEA study will give us new understanding about the causes of atherosclerosis, including the discovery of new genes and new pathways that could guide the development of new drug treatments that may be more effective in preventing the development of heart disease," said Herrington.

The researchers will take advantage of data from two large-scale studies: LSU Health Sciences Center’s Pathobiological Determinants of Atherosclerosis in Youth (PDAY) stud
'"/>

Source:Wake Forest University Baptist Medical Center


Page: 1 2

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/5/2009)...e University have developed synthetic molecules ca...IV and HIV-infected cells, as well as to prostate ...the Journal of the American Chemical Society , co... diseases. , The molecules called "antibody-re...body-recruiting molecule targeting prostate cancer...
(Date:11/4/2009)...are reluctant to officially endorse green tea as a...row about its protective effects, including result...esearch , a journal of the American Association fo...n oral cancer. , Vassiliki Papadimitrakopoulo, ...horacic/Head and Neck Medical Oncology at the Univ...
(Date:11/4/2009)...ies of Long Beach and Riverside are responsible fo...d asthma, and the true impact of air pollution and...erestimated, according to researchers at the Unive..., which appears in an online edition of the Ameri... percent of all childhood asthma cases in Long Bea...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Sleep Deprivation Might Lead to Alzheimers 58288 1Sleep Deprivation Might Lead to Alzheimers 58288 2Vision for a Nation 3A Universal Access to Eyeglasses for the People of Rwanda 58283 1Vision for a Nation 3A Universal Access to Eyeglasses for the People of Rwanda 58283 2Mayo Clinic Offers Perspective on Health Care Reform in New England Journal of Medicine 58278 1Mayo Clinic Offers Perspective on Health Care Reform in New England Journal of Medicine 58278 2
...Calif., March 12 (OTC Bulletin Board: CICI) Commu..."Company"), a leading supplier of electronic signa...the financial industry* and the recognized leader*...day its financial results for the fourth quarter a...venues for the three months ended December 31, 200...
...Researchers at the University of Florida have intr... ,Delicious, ripens early, produces high yields, a...exceptional taste and texture with an edible skin,... and the potential for wine production. The name ,...ineyard visitors who sampled the fruit., According...
...f. - The most abundant material on Earth exhibits ... extreme conditions. , Lawrence Livermore Nationa...hot dense environments, plays an unexpected role i...st is a compound that speeds chemical reactions wi...mon catalysts. But water rarely, if ever, acts as ...
Other Biology News:Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 6Water acts as catalyst in explosives 2
(Date:11/6/2009)...wire-FirstCall/ -- BioSpecifics Technologies Corp....eloping first-in-class collagenase-based products,...rd quarter ended September 30, 2009. ,, "We we..., the FDA,s Arthritis Advisory Committee unanimous... XIAFLEX(TM) for the treatment of Dupuytren,s dise...
(Date:11/6/2009)...ire/ -- Myriant Technologies LLC ("Myriant"), a pr...f renewable bio-chemicals, Uhde Corporation of Am...mbH, one of the world,s leading engineering contra...the engineering, procurement & construction (E...ed on renewable feedstocks. The execution of this...
(Date:11/6/2009)...ewswire-FirstCall/ -- ,, 3Q09 Corporate High... E.U. Marketing Authorization to Astellas Pharma E...al readiness activities Expanded management team ...nd Director, Commercial Operations Appointed Brad...mittee chairman , Upcoming 2009 Milestones:...
(Date:11/6/2009)...rstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDA...unced updated results from a Phase II study of int...astatic to the lung in a poster presentation at th...eeting held in Miami Beach, Florida, from November...Phase II Study of Intravenous REOLYSIN (Wild-type ...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
...st, Inc.,(NYSE: BMR ) today announced the signing...are feet at the Pacific Research Center, BioMed,s ...yStar Technologies, Inc.,(Nasdaq: DSTI ) will joi...the Pacific Research Center in the East Bay of San...ar is engaged in the development, manufacturing an...
...isnt always easy. However, shaking the bottle befo...to flow more freely because it becomes more fluid ... a liquid such as water does not become a gel when...e March 14 issue of the journal Physical Review Le...n oil are confined to a nanometer-sized space, the...
...rated,(Nasdaq: GPRO ) announced today that the Co...l Health Care Conference on May 6 at approximately...duled to be webcast live,and may be accessed throu...website at http://www.gen-probe.com . The webcast...., About Gen-Probe, Gen-Probe Incorporated is a ...
Other Biology Technology:BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 2BioMed Realty Trust Announces 140,000 Square Foot Lease With DayStar Technologies at Pacific Research Center 3Atomic force microscopy reveals liquids adjust viscosity when confined, shaken 2Atomic force microscopy reveals liquids adjust viscosity when confined, shaken 3Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference 2
...g system from Molecular Devices provides precise d...nt. The system handles a variety of plate formats ...-welland is the first to handle 1536-well micropla...ense from four different channels to accommodate u...
...you to identify over 150 peptide modifications sim...rms, protein subsets, and suppress false positives...ons and relationships easily. The software is idea...expression analysis for discovery research. The Pa...
Rabbit Anti-Human Rad51 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: